|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depressive Disorder | |||||
| Mood Disorder | |||||
| Psychomotor Agitation | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Depression | |||||
| Disease | |||||
| Mood Disorders | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| Dyskinesias | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurobehavioral Manifestations | |||||
| Neurologic Manifestations | |||||
| Pathologic Processes | |||||
| Psychomotor Disorders | |||||
| Signs and Symptoms | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Progesterone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Progestins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||